Elif Uslu

This paper synthesizes 6-sulfo sialyl Lewisx glycans to identify MERS-CoV's preferred receptor and develops a multivalent inhibitor.

This study uses self-assembling nanoparticles to investigate how multivalent HA binding affects influenza virus interaction with glycan surfaces, finding that valency and receptor density significantly influence binding strength and mode.

This study identifies epistatic interactions in H3N2 influenza viruses that enable reversion to bind sialylated diLacNAc glycans, impacting receptor specificity and vaccine strain selection.

The paper shows that a single Q226L mutation in the HA protein of a 2.3.4.4e H5 virus allows it to bind human-type receptors, unlike a modified 2.3.4.4b virus.